TFR2 and erythroleukemia: It was shown that gastric cancer–derived EVs can increase pAkt and proliferation of recipient cells (70), and transferrin receptor 2 is released by hepatoblastoma and erythroleukemia-derived exosomes and activates signal transduction through the MAPK pathway (71).